← Back to Screener
ScreenerNewsCompareWatchlist
VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesNewsCompareWatchlist
AnalyzeValuationTotal ReturnDCA CalculatorInsider Activity
  1. Home
  2. GNFT
  3. P/E History
OverviewPriceRevenueEarningsP/ERatiosDividendTargets

GNFT logoGenfit S.A. (GNFT) P/E Ratio History

Historical price-to-earnings valuation from 2022 to 2023

Current P/E
256.9
Overvalued
5Y Avg P/E
6.7
+3715% vs avg
PE Percentile
100%
High
PEG Ratio
N/A
N/A
TTM EPS$-0.33
Price$8.95
5Y PE Range4.4 - 9.1
Earnings Yield0.39%

Loading P/E history...

GNFT Valuation Context

How does the current P/E compare to historical and market benchmarks?

vs. 5Y Average
256.9vs6.7
+3715%
Premium vs History
vs. Healthcare
256.9vs22.3
+1051%
Above Sector
vs. S&P 500
256.9vs25.1
+922%
Above Market
PEG Analysis
N/A
P/E ÷ EPS Growth
Based on 105% EPS growth (1Y)
Export Data

P/E Ratio Analysis

As of May 8, 2026, Genfit S.A. (GNFT) trades at a price-to-earnings ratio of 256.9x, with a stock price of $8.95 and trailing twelve-month earnings per share of $-0.33.

The current P/E is 3715% above its 5-year average of 6.7x. Over the past five years, GNFT's P/E has ranged from a low of 4.4x to a high of 9.1x, placing the current valuation at the 100th percentile of its historical range.

Compared to the Healthcare sector median P/E of 22.3x, GNFT trades at a 1051% premium to its sector peers. The sector includes 241 companies with P/E ratios ranging from 0.0x to 177.5x.

Relative to the broader market, GNFT commands a significant premium over the S&P 500 median P/E of 25.1x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.

For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our GNFT DCF Valuation Calculator →

Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.

GNFT P/E vs Peers

P/E ratio compared to closely matched public peers

CompanyMarket CapP/E RatioPEG RatioEPS Growth (1Y)
HALO logoHALOHalozyme Therapeutics, Inc.
$8B25.5Lowest1.11Best-25%
ALNY logoALNYAlnylam Pharmaceuticals, Inc.
$39B127.0-+207%Best
LLY logoLLYEli Lilly and Company
$921B42.51.47+96%

Peers sorted by market capitalization. P/E below peers may indicate undervaluation or lower growth expectations. Consider PEG ratio for growth-adjusted comparison.

GNFT Historical P/E Data (2022–2023)

Quarterly P/E ratios calculated from closing price and TTM EPS

QuarterDatePriceTTM EPSP/E Ratiovs Avg
FY2023 Q2Fri Jun 30 2023 00:00:00 GM$3.54$0.399.1x+35%
FY2022 Q4Sat Dec 31 2022 00:00:00 GM$4.39$1.004.4x-35%

Average P/E for displayed period: 6.7x

See GNFT's True Return

Price is only half the story. See total return with reinvested dividends.

Launch Calculator

Is GNFT Undervalued?

DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.

View Valuation

Compare GNFT vs DBVT

Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..

Start Comparison

GNFT — Frequently Asked Questions

Quick answers to the most common questions about buying GNFT stock.

Is GNFT stock overvalued or undervalued?

GNFT trades at 256.9x P/E, above its 5-year average of 6.7x. The 100th percentile ranking indicates a premium to historical valuation.

How does GNFT's valuation compare to peers?

Genfit S.A. P/E of 256.9x compares to sector median of 22.3x. The premium reflects expected growth above peers.

What is GNFT's PEG ratio?

GNFT PEG ratio is N/A. Above 2.0 indicates premium valuation relative to growth rate. Historical P/E data spans 2022-2023.

VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screener
  • Themes
  • Market Valuation
  • Valuation
  • Compare
  • Total Return
  • DCA Calculator
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Follow @VCPScanner on X

Get weekly stock ideas — free

© 2026 VCP Scanner. All rights reserved.
About·Privacy Policy·Terms of Service
Not financial advice. Do your own research.

GNFT P/E Ratio History (2022–2023)

P/E ratio calculated as closing price divided by trailing 12-month diluted EPS at each quarter end.